Catharina Larsson Selected Research

trichostatin A (A 300)

1/2013	Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
7/2008	Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catharina Larsson Research Topics

Disease

93	Neoplasms (Cancer) 06/2023 - 06/2002
18	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 09/2002
17	Adenoma (Adenomas) 06/2022 - 09/2002
14	Follicular Adenocarcinoma 01/2023 - 04/2003
13	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2018 - 10/2003
12	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2005
11	Pheochromocytoma 01/2019 - 08/2002
10	Carcinoma (Carcinomatosis) 05/2021 - 09/2002
10	Paraganglioma (Paragangliomas) 10/2020 - 07/2002
10	Carcinogenesis 01/2020 - 04/2003
7	Adrenocortical Carcinoma 11/2022 - 10/2011
6	Papillary Thyroid Cancer 01/2023 - 04/2003
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021 - 05/2013
4	Neuroblastoma 01/2021 - 07/2008
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2019 - 01/2013
4	Primary Hyperparathyroidism 05/2016 - 01/2006
4	Anaplastic Thyroid Carcinoma 11/2014 - 04/2003
3	Merkel Cell Carcinoma 01/2020 - 02/2014
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2016 - 02/2009
3	Leukemia 01/2013 - 09/2008
3	Hyperparathyroidism 01/2012 - 10/2003
3	Sarcoma (Soft Tissue Sarcoma) 09/2008 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 02/2006 - 04/2003
2	Adrenocortical Adenoma (Disease, Conn's) 11/2022 - 04/2014
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 10/2022 - 01/2022
2	Uterine Cervical Dysplasia 05/2017 - 11/2009
2	Infections 02/2014 - 11/2009
2	Papillary Carcinoma 04/2012 - 10/2010
2	T-Cell Leukemia (Leukemia, T Cell) 07/2011 - 04/2009
2	follicular Thyroid cancer 10/2008 - 03/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2007 - 03/2005
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2006 - 08/2002
2	Malignant Fibrous Histiocytoma 04/2004 - 09/2003
2	Synovial Sarcoma (Synovioma) 04/2003 - 06/2002
1	Islet cell tumor syndrome 01/2019
1	Skin Neoplasms (Skin Cancer) 11/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017
1	Testicular Germ Cell Tumor 01/2017

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2003
19	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023 - 11/2009
18	Messenger RNA (mRNA)IBA 05/2022 - 09/2002
13	RacivirIBA 01/2023 - 04/2003
13	MicroRNAs (MicroRNA)IBA 11/2022 - 08/2010
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2002
7	CatecholaminesIBA 01/2022 - 08/2002
5	RNA (Ribonucleic Acid)IBA 05/2021 - 06/2002
5	CalciumIBA 01/2018 - 11/2006
4	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 04/2014
3	ParaffinIBA 06/2023 - 03/2002
3	CateninsIBA 05/2022 - 10/2010
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 12/2012
3	EnzymesIBA 01/2020 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 04/2012
3	hydrogen sulfite (bisulfite)IBA 06/2013 - 05/2008
3	Insulin-Like PeptidesIBA 01/2013 - 01/2005
3	Complementary DNA (cDNA)IBA 02/2006 - 12/2002
2	Formaldehyde (Formol)FDA Link 06/2023 - 05/2021
2	AntibodiesIBA 01/2023 - 01/2016
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2022
2	Uridine Monophosphate (UMP)IBA 09/2019 - 01/2018
2	Chloride Channels (Chloride Channel)IBA 07/2019 - 08/2014
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 04/2014
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 01/2016
2	SurvivinIBA 10/2016 - 02/2014
2	AldosteroneIBA 04/2014 - 07/2009
2	trichostatin A (A 300)IBA 01/2013 - 07/2008
2	Hormones (Hormone)IBA 01/2012 - 01/2011
2	PPAR gammaIBA 09/2008 - 09/2003
2	Cyclin D1IBA 09/2008 - 03/2005
2	AntigensIBA 03/2005 - 06/2002
2	SYT-SSX fusion proteinIBA 04/2003 - 06/2002
1	Thyroglobulin FDA Link 01/2023
1	5-hydroxymethylcytosineIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022
1	RNA Splicing FactorsIBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	pevonedistatIBA 10/2019
1	Proteasome InhibitorsIBA 10/2019
1	NEDD8 ProteinIBA 10/2019
1	Bortezomib (Velcade)FDA Link 10/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	Chromogranin BIBA 01/2019
1	ElementsIBA 01/2019
1	ProteomeIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Mitotane (Lysodren)FDA Link 01/2017
1	Differentiation AntigensIBA 01/2017
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	human CYP2A7 protein (CYP2A7)IBA 01/2017
1	CytochromesIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2016
1	25-hydroxyvitamin DIBA 05/2016

Therapy/Procedure

10	Therapeutics 03/2022 - 09/2008
3	Drug Therapy (Chemotherapy) 01/2019 - 09/2008